SCHEMBL23555643

SCHEMBL23555643

CC(C)(C)OC(=O)N1CC[C@@H](NCCO)C1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.51
USP30 Q70CQ3 7/20 0.48
HSD11B1 P28845 2/20 0.45
CYP2C9 P11712 1/20 0.45
ALDH1A1 P00352 3/20 0.45
NR1H2 P55055 1/20 0.44
MAPT P10636 2/20 0.44
NPC1 O15118 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HPGD P15428 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30999407 0.92 EPHX1 (0.49) EPHX1USP30HSD11B1CYP2C9ALDH1A1
SCHEMBL1990841 0.92 USP30 (0.51) EPHX1USP30ALDH1A1NR1H2MAPT
SCHEMBL948136 0.91 EPHX1 (0.57) EPHX1ALDH1A1NR1H2MAPTNPC1
SCHEMBL18556969 0.90 EPHX1 (0.52) EPHX1USP30HSD11B1CYP2C9ALDH1A1
SCHEMBL13696753 0.90 EPHX1 (0.52) EPHX1USP30HSD11B1CYP2C9ALDH1A1
SCHEMBL25237250 0.90 EPHX1 (0.52) EPHX1USP30HSD11B1CYP2C9ALDH1A1
SCHEMBL2907249 0.88 NR1H2 (0.53) EPHX1USP30ALDH1A1NR1H2MAPT
SCHEMBL31421132 0.87 EPHX1 (0.53) EPHX1USP30HSD11B1CYP2C9ALDH1A1
SCHEMBL24033437 0.86 EPHX1 (0.49) EPHX1USP30HSD11B1CYP2C9ALDH1A1
SCHEMBL13712553 0.86 USP30 (0.49) EPHX1USP30HSD11B1CYP2C9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021121363-A1 HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS JANSSEN PHARMACEUTICA NV (BE) 2021-06-24 WO disclosed